Skip to main content
Caplight Logo









Tandem Nano

Tandem Nano

Private
LiverpoolHealthcare & Life Scienceshttps://extentuspharma.com

Last Round

Pre Seed

Apr 1, 2019

Company Overview

Tandem Nano operates in Healthcare & Life Sciences and is based in Liverpool. Its latest recorded funding round was a Pre Seed round in April 2019.

Tandem Nano is a biotechnology company that develops a solid drug nanoparticle technology platform designed to transform the delivery of active compounds.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Tandem Nano Comparables

Compare Tandem Nano with similar companies based on industry and business-model similarity.

Tandem Nano comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
InnoCore Pharmaceuticals
78%
Nanexa
70%
DelSiTech
70%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Tandem Nano Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedApr 1, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Tandem Nano Investors

Notable investors and investment history

Tandem Nano investors
InvestorRounds
University of Liverpool Enterprise Investment FundPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2019

    Led by University of Liverpool Enterprise Fund.

Book a demo to see all signals

For institutional investors. Book with your work email.

Tandem Nano Filings

Explore SEC and related filing metadata, where available.

Tandem Nano filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Tandem Nano's valuation, stock price, and market status.

Is Tandem Nano a public or private company?

Tandem Nano is a private company.

What is the current stock price of Tandem Nano?

Tandem Nano is a private company, so its shares have no public market price. Caplight tracks Tandem Nano's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Tandem Nano worth (valuation)?

Valuation information for Tandem Nano is not publicly available.

Can I buy Tandem Nano stock?

Tandem Nano shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Tandem Nano's last funding round?

Tandem Nano's most recent funding round was Pre Seed on April 1, 2019.

Who are the main investors in Tandem Nano?

Key investors in Tandem Nano include University of Liverpool Enterprise Investment Fund.

Will Tandem Nano IPO soon?

No public IPO plans have been announced for Tandem Nano.

How can I track Tandem Nano secondary market activity?

Caplight tracks bids, offers, and trades in Tandem Nano's shares on secondary markets.

Firmographic Details

HeadquartersLiverpool
Year Founded2019
Last FundingApr 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?